02493 MABWELL-B
Closed Add to Porfolio| Index Constituent : None | |||
| Major Shareholders | TANG Chunshan & Associates (38.33%) | Sector | Health Care & Biotechnology |
|---|---|---|---|
| Web Site | http://www.mabwell.com | Tel | (86 021) 5833-2260 |
| ir@mabwell.com | Fax | N/A | |
| Related Equities | N/A | ||
| Principal Activities | The Group is principally engaged in the research and development of new molecular entity drugs, and its business scope is research, development, transfer, technical services for and production and sales of new pharmaceutical and chemical technologies and new pharmaceutical products in the Peoples Republic of China (the PRC). | ||
Consolidated List of Substantial Shareholders
| Name | Number of Shares Interested | % of Issued Share Capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Complete List of Directors
| Director's Name | Number of Shares Interested | % of issued share capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
